高通量血液透析治疗慢性肾功能衰竭尿毒症临床观察
CSTR:
作者:
作者单位:

作者简介:

何奕初,男,主治医师,主要从事慢性肾脏病的防治、终末期肾脏病的血液净化治疗工作。

通讯作者:

中图分类号:

R 692.5

基金项目:


Clinical Observation on Treatment of Uremia with Chronic Renal Failure by High-Throughput Hemodialysis
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    摘 要目的:探讨高通量血液透析治疗慢性肾功能衰竭尿毒症患者的临床效果。 方法:选取 2020 年 1 月至 2021 年 1 月 阳春市中医院收治的 68 例慢性肾功能衰竭尿毒症患者作为研究对象,根据数字表法进行随机分组,包括对照组 34 例和观 察组 34 例。对照组患者行常规通量血液透析治疗,观察组患者行高通量血液透析治疗,比较两组患者治疗前后肾功能指标、 炎症因子水平、血磷(P)水平、β2– 微球蛋白(β2–MG)水平,以及两组患者并发症发生情况。 结果:治疗前两组患者 血肌酐(Scr)、血尿素氮(BUN)、β2–MG 水平比较,差异无统计学意义(P > 0.05);治疗后观察组患者 Scr、BUN、 β2–MG 水平均低于对照组,差异具有统计学意义(P < 0.05)。治疗前两组患者白细胞介素 –6(IL–6)、C 反应蛋白(CRP) 和 P 水平比较,差异无统计学意义(P > 0.05);治疗后,观察组患者 CRP、IL–6、P 水平均低于对照组,差异具有统计 学意义(P < 0.05)。观察组患者并发症总发生率显著低于对照组,差异具有统计学意义(P < 0.05)。 结论:慢性肾功能 衰竭尿毒症患者进行高通量血液透析治疗能够有效改善其受损的肾功能,纠正炎症因子水平,同时具有较高的治疗安全性。

    Abstract:

    AbstractObjectiveTo investigate the clinical effect of high-throughput hemodialysis in uremia patients with with chronic renal failure. Methods A total of 68 uremia patients with chronic renal failure admitted to Yangchun Hospital of Traditional Chinese Medicine from January 2020 to January 2021 were selected as the research objects, and were randomly divided into control group and observation group, with 34 cases in each group, according to the number table method. The control group received routine flux hemodialysis, and the observation group received high-throughput hemodialysis. The renal function indexes, inflammatory factor levels, blood phosphorus (P) levels, β2-microglobulin (β2-MG) levels, and the incidence of complications were compared between the two groups before and after treatment. Results A total of 68 uremia patients with chronic renal failure admitted to Yangchun Hospital of Traditional Chinese Medicine from January 2020 to January 2021 were selected as the research objects, and were randomly divided into control group and observation group, with 34 cases in each group, according to the number table method. The control group received routine flux hemodialysis, and the observation group received high-throughput hemodialysis. The renal function indexes, inflammatory factor levels, blood phosphorus (P) levels, β2-microglobulin (β2-MG) levels, and the incidence of complications were compared between the two groups before and after treatment. Conclusion High-throughput hemodialysis treatment in uremia patients with chronic renal failure can effectively improve their impaired renal function, correct inflammatory factor levels, and have high treatment safety.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2021-10-29
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-07-26
  • 出版日期:
文章二维码
特别声明

近期有不法分子冒充我刊名义给作者打电话或发邮件,编造各种理由要求添加微信或QQ、伪造复制我刊编辑部公章发放假冒录用通知书等等各种方式试图骗取作者钱财。为强化编辑部工作规范,加强单位公章管理,维护作者的正当权益和财产利益, 我刊在此郑重声明:(1)编辑部与作者沟通方式为电话和邮件,在本刊唯一官方网站(http:/szzxyjhzz.szrch.com)“联系我们”下拉菜单,或者网站最下端信息栏可以查询),绝对不会要求作者添加微信或QQ。 (2)自2025年2月1日起,注销废除“深圳中西医结合杂志编辑部”电子公章;我刊稿件录用通知调整为加盖编辑部实体公章的纸质文件或其扫描件,录用稿件仅收取合理版面制作费和审稿费,收款单位为“深圳市第二人民医院”对公账户,其他加盖电子公章或涉及私人账户者均为伪造假冒。望广大作者提高警惕,谨防上当受骗。 《深圳中西医结合杂志》编辑部

关闭